Dinesh V Ph D Patel Insider Trading Activity
Dinesh V Ph D Patel has been net-selling over the last 12 months with 0 purchases and 9 sales across 1 company.
PTGX is the most-traded position with 9 trades. The largest single transaction was a sale of PTGX for $7.5M on May 12, 2026.
Performance Scorecard
Forward stock performance after each transaction by Dinesh V Ph D Patel. Buy returns measure price movement after open-market purchases; sell-avoided measures the loss avoided after open-market sales. Success rate counts trades where the insider's direction was right.
| PERIOD | AVG BUY RETURN | AVG SELL AVOIDED | SUCCESS RATE | TRADES |
|---|---|---|---|---|
| 30 days | — | -3.3% | 8% | 12 |
| 90 days | — | -25.9% | 0% | 11 |
| 120 days | — | -35.6% | 0% | 11 |
Performance based on stock price movement after each transaction date. Past results do not predict future returns. Not financial advice.
Price & Trades
Pro: Trade MarkersPTGX · Protagonist Therapeutics, Inc
🔒 Subscribe to see trade entries
Pro members see exactly when Dinesh V Ph D Patel bought and sold PTGX.
Upgrade to ProRecent Trades
| DATE | TICKER | TYPE | SHARES | PRICE | VALUE | Δ OWNED | ROLE | FILING |
|---|---|---|---|---|---|---|---|---|
May 12, 2026 | PTGX | Sell | 75,000 | $100.12 | $7.5M | −12.5% | CEO | |
Mar 25, 2026 | PTGX | Sell | 54,641 | $101.00 | $5.5M | −9.4% | CEO | |
Mar 24, 2026 | PTGX | Sell | 59 | $101.00 | $6K | −0.0% | CEO | |
Jan 27, 2026 | PTGX | Sell | 4,068 | $83.19 | $338K | −0.7% | CEO | |
Jan 26, 2026 | PTGX | Sell | 10,685 | $84.00 | $898K | −1.8% | CEO | |
Jan 26, 2026 | PTGX | Sell | 14,205 | $84.05 | $1.2M | −2.4% | CEO | |
Jan 23, 2026 | PTGX | Sell | 19,315 | $84.59 | $1.6M | −3.3% | CEO | |
Jan 20, 2026 | PTGX | Sell | 34,438 | $82.48 | $2.8M | −5.6% | CEO | |
Jul 25, 2025 | PTGX | Sell | 10,415 | $54.78 | $571K | −2.0% | CEO | |
Jul 23, 2025 | PTGX | Sell | 17,520 | $54.79 | $960K | −3.2% | CEO | |
Jul 22, 2025 | PTGX | Sell | 22,065 | $55.05 | $1.2M | −3.9% | CEO | |
Jul 21, 2025 | PTGX | Sell | 12,859 | $54.86 | $705K | −2.2% | CEO |
Top Companies Traded
| TICKER | COMPANY | TRADES | TOTAL VOLUME |
|---|---|---|---|
| PTGX | Protagonist Therapeutics, Inc | 12 | $23.4M |
Other insiders at Protagonist Therapeutics, Inc
4 other tracked filers at PTGX.